These aren't happy times for the pharmaceutical industry. Day by day, bad news accumulates, and even the Pharmaceutical Research and Manufacturers Association (PhRMA), the industry's trade organization, acknowledges that something has to give:
Study finds reduced CIN3+ risk from early HPV vaccination
April 17th 2024A recent study found that human papillomavirus vaccination when aged under 20 years, coupled with active surveillance for cervical intraepithelial neoplasia grade 2, significantly lowers the risk of cervical intraepithelial neoplasia grade 3 or cervical cancer.